Incyte
INCY
#1110
Rank
ยฃ15.10 B
Marketcap
ยฃ76.96
Share price
2.05%
Change (1 day)
31.06%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2025 (TTM): ยฃ3.65 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is ยฃ3.61 Billion. In 2024 the company made a revenue of ยฃ3.37 Billion an increase over the revenue in the year 2023 that were of ยฃ2.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ3.65 B8.16%
2024 ยฃ3.37 B16.51%
2023 ยฃ2.90 B3.38%
2022 ยฃ2.80 B26.83%
2021 ยฃ2.21 B13.08%
2020 ยฃ1.95 B18.84%
2019 ยฃ1.64 B11.04%
2018 ยฃ1.48 B30.43%
2017 ยฃ1.13 B26.84%
2016 ยฃ0.89 B76.18%
2015 ยฃ0.50 B54.82%
2014 ยฃ0.32 B52.68%
2013 ยฃ0.21 B17.08%
2012 ยฃ0.18 B202.43%
2011 ยฃ60.77 M-44.78%
2010 ยฃ0.11 B1822.01%
2009 ยฃ5.72 M114.06%
2008 ยฃ2.67 M-84.57%
2007 ยฃ17.33 M22.84%
2006 ยฃ14.11 M210.15%
2005 ยฃ4.55 M-18.88%
2004 ยฃ5.6 M-78.69%
2003 ยฃ26.32 M-58.46%
2002 ยฃ63.37 M-58.09%
2001 ยฃ0.15 B16.24%
2000 ยฃ0.13 B33.85%
1999 ยฃ97.19 M19.89%
1998 ยฃ81.06 M49.29%
1997 ยฃ54.3 M126.23%
1996 ยฃ24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ27.00 B 647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.60 B 1,134.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 1,204.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.13 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.29 B-91.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.31 B 1,071.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
ยฃ70.8 M-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ56.87 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA